Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997-2003

Alexandra Schifferli, Rodo O von Vigier, Matteo Fontana, Giuseppina Spartà, Hans Schmid, Mario G Bianchetti, Christoph Rudin, Swiss Pediatric Surveillance Unit, Ch Aebi, V Bernet-Büttiker, P Hüppi, B Laubscher, Ch Rudin, H Zimmermann, D Beeli, Alexandra Schifferli, Rodo O von Vigier, Matteo Fontana, Giuseppina Spartà, Hans Schmid, Mario G Bianchetti, Christoph Rudin, Swiss Pediatric Surveillance Unit, Ch Aebi, V Bernet-Büttiker, P Hüppi, B Laubscher, Ch Rudin, H Zimmermann, D Beeli

Abstract

Hemolytic-uremic syndrome (HUS) is a leading cause of acute renal failure in childhood. In its typical presentation, it is preceded by an episode of diarrhea mostly due to Shiga-toxin-producing Escherichia coli. There is important geographical variation of many aspects of this syndrome. Nationwide data on childhood HUS in Switzerland have not been available so far. In a prospective national study through the Swiss Pediatric Surveillance Unit 114 cases (median age 21 months, 50% boys) were reported between April 1997 and March 2003 by 38 pediatric units (annual incidence 1.42 per 10(5) children < or =16 years). Shiga-toxin-producing E. coli were isolated in 32 (60%) of tested stool samples, serotype O157:H7 in eight. Sixteen children presented with only minimal renal involvement, including three with underlying urinary tract infection. Six patients presented with atypical hemolytic-uremic syndrome, and six with HUS due to invasive Streptococcus pneumoniae infection. Mortality was 5.3%, including two out of six children with S. pneumoniae infection. The severity of thrombocytopenia and the presence of central nervous system involvement significantly correlated with mortality. In conclusion, childhood HUS is not rare in Switzerland. Contrasting other countries, E. coli O157:H7 play only a minor role in the etiology. Incomplete manifestation is not uncommon.

References

    1. Kidney Int. 2006 Aug;70(3):423-31
    1. Schweiz Med Wochenschr. 1955 Sep 20;85(38-39):905-9
    1. JAMA. 2003 Sep 10;290(10):1360-70
    1. Lancet. 2003 Nov 8;362(9395):1542-7
    1. J Pediatr. 1990 Apr;116(4):589-92
    1. J Pediatr. 1994 Oct;125(4):511-8
    1. Emerg Infect Dis. 1997 Oct-Dec;3(4):578-9
    1. Clin Infect Dis. 1998 Aug;27(2):310-5
    1. Pediatr Nephrol. 2008 Nov;23(11):1951-6
    1. J Infect Dis. 2001 Apr 1;183(7):1063-70
    1. Nephrol Dial Transplant. 2004 Jul;19(7):1687-93
    1. Pediatr Nephrol. 2008 Oct;23(10):1761-7
    1. J Infect Dis. 1989 Sep;160(3):469-75
    1. Clin Infect Dis. 2000 Jul;31(1):192-6
    1. Epidemiol Infect. 2000 Jun;124(3):343-9
    1. N Engl J Med. 1995 Aug 10;333(6):364-8
    1. J Pediatr. 1995 Sep;127(3):364-7
    1. Schweiz Med Wochenschr. 1997 Jul 22;127(29-30):1229-33
    1. Arch Dis Child. 2001 Aug;85(2):125-31
    1. Schweiz Med Wochenschr. 1993 Jul 24;123(29):1439-44
    1. Pediatr Nephrol. 2008 Oct;23(10):1749-60
    1. N Engl J Med. 2000 Jun 29;342(26):1930-6
    1. Clin Infect Dis. 2006 Dec 15;43(12):1587-95
    1. Pediatr Infect Dis J. 1997 Aug;16(8):828
    1. Pediatr Nephrol. 2003 Nov;18(11):1193-4
    1. Pediatrics. 2005 Jun;115(6):e673-80
    1. Pediatr Nephrol. 2000 May;14(5):436-7
    1. Pediatr Nephrol. 2008 Sep;23(9):1423-4
    1. Pediatr Nephrol. 2008 Nov;23(11):1957-72
    1. J Infect Dis. 1990 Aug;162(2):553-6
    1. Pediatrics. 1994 Jul;94(1):35-40
    1. J Pediatr. 2007 Aug;151(2):140-4
    1. Infection. 1999 Nov-Dec;27(6):341-7
    1. J Infect Dis. 2002 Aug 15;186(4):493-500
    1. Pediatrics. 1997 Jul;100(1):E12
    1. JAMA. 1994 Nov 2;272(17):1349-53

Source: PubMed

3
订阅